BlockBeats News, October 6th, According to official sources, Silo Pharma, Inc. (Nasdaq: SILO), a diversified biopharmaceutical and cryptocurrency asset management company, today announced its initial purchase of ResearchCoin (RSC) as a key step in its expanded digital asset asset strategy, aimed at capturing long-term value from emerging multi-chain opportunities.
RSC is the native token of the decentralized research collaboration platform ResearchHub, co-founded by Coinbase CEO Brian Armstrong in 2019.
Eric Weisblum, CEO of Silo Pharma, said: “By acquiring RSC, we are not only participating in the growing decentralized science (DeSci) movement, but also diversifying assets and potentially adding value for shareholders. The investment in ResearchCoin highlights our focus on the modernization of research collaboration and support for blockchain-driven innovation to become a cornerstone of biomedical discovery.”
